American Campus Communities, Inc. (ACC)
Price:
65.42 USD
( + 0.05 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
American Homes 4 Rent
VALUE SCORE:
0
2nd position
Essex Property Trust, Inc.
VALUE SCORE:
11
The best
AvalonBay Communities, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
American Campus Communities, Inc. is the largest owner, manager and developer of high-quality student housing communities in the United States. The company is a fully integrated, self-managed and self-administered equity real estate investment trust (REIT) with expertise in the design, finance, development, construction management and operational management of student housing properties. As of September 30, 2020, American Campus Communities owned 166 student housing properties containing approximately 111,900 beds. Including its owned and third-party managed properties, ACC's total managed portfolio consisted of 204 properties with approximately 139,900 beds.
NEWS

Aker Carbon Capture: Second-Quarter and Half-year Results 2025
prnewswire.com
2025-07-15 01:10:00FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Carbon Capture ASA ("ACC ASA") today publishes its second-quarter and half-year results for 2025. In the second quarter, ACC ASA made a strategic decision to divest its 20 percent ownership stake in SLB Capturi AS, through a sale to Aker which was completed 14 May 2025.

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
globenewswire.com
2025-04-15 08:00:00Precise Volume Measurement Prior to Discharge Identifies Mortality Risk Oak Ridge, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced compelling new data presented at the American College of Cardiology (ACC) 74th Annual Scientific Session and Expo held in Chicago from March 29-31st. Research from The Minneapolis Heart Institute Foundation® and Allina Health Minneapolis Heart Institute® demonstrated that hospitalized heart failure patients who received blood volume analysis (BVA) prior to hospital discharge could be used to stratify those with a substantially better survival rate.

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
globenewswire.com
2025-03-31 08:05:00SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago, IL. Drawing on data from more than 1.1 million patients who used iRhythm's Zio® long-term continuous monitoring (LTCM) ECG devices, these studies demonstrate that short-term (24–48-hour) monitoring, such as with Holter devices, fails to detect a significant proportion of actionable arrhythmias—even in patients reporting “daily symptoms”—and that Symptom–Rhythm Correlation (SRC) is notably low for most arrhythmias, underscoring that selection of monitoring duration based on the frequency of symptoms alone can lead to undetected (missed) actionable1 arrhythmias.

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
globenewswire.com
2025-03-29 14:33:00Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD)1. These new data from the phase 3b trial were featured during a late-breaking clinical trial session at the American College of Cardiology's (ACC) Annual Scientific Session and Expo in Chicago, US and simultaneously published today in New England Journal of Medicine 2.

Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology's Annual Scientific Session & Expo (ACC.25)
globenewswire.com
2025-03-29 14:30:00– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction (p=0.001), assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile –

ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
businesswire.com
2025-03-27 09:00:00CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway. GE HealthCare has been investing in.

ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
businesswire.com
2025-03-25 06:00:00WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American College of Cardiology (ACC) 74th Annual Scientific Session & Expo 2025, taking place in Chicago, IL, from March 29-31, 2025. Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for the treatment of adult pati.

BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions
globenewswire.com
2025-03-24 07:30:00PALO ALTO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that cardiovascular outcomes data in patients with variant and wild-type ATTR-CM from the ATTRibute-CM, its Phase 3 study of acoramidis in ATTR-CM, will be shared in a flatboard poster presentation at the American College of Cardiology (ACC) Annual Scientific Sessions & Expo, taking place in Chicago, Illinois on March 29-31, 2025. Additionally, BridgeBio was selected to share five poster presentations and two moderated posters on ATTR-CM.

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo
globenewswire.com
2025-03-19 07:30:00DUBLIN and BRIDGEWATER, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be presented at the American College of Cardiology's Annual Scientific Session & Expo, March 29-31, 2025, in Chicago, IL.

Stellantis-backed ACC to expand French gigafactory
reuters.com
2024-12-11 08:31:17Battery maker Automotive Cells Company (ACC) is set to sign a new loan to finance the second production block of its gigafactory in northern France, a company spokesman said, as it ramps up output despite Europe's sluggish electric vehicle market.

American Campus Communities Promotes Kim Voss as New Chief Financial Officer
businesswire.com
2022-11-14 17:50:00AUSTIN, Texas--( BUSINESS WIRE )--American Campus Communities (ACC), the nation's largest student housing manager, owner and developer has announced the promotion of Kim Voss to Chief Financial Officer (CFO).

Alternative Credit Managers Launch ESG Integrated Disclosure Tool
businesswire.com
2022-11-08 08:30:00NEW YORK & LONDON--(BUSINESS WIRE)--A group of leading alternative asset managers and industry bodies in the private and broadly syndicated credit markets have today announced the launch of the ESG Integrated Disclosure Project (ESG IDP) template.

Bloomberg Law to Feature Latest Legal Intelligence and Tools for Corporate Counsel at 2022 ACC Meeting
headlinesoftoday.com
2022-10-19 10:13:00ARLINGTON, Va., Oct. 19, 2022 /PRNewswire/ — Bloomberg Law today announced that it will highlight its resources and workflow tools at the annual meeting of the Association of Corporate Counsel (ACC) taking place in Las Vegas October 23-26. Bloomberg Law will showcase its legal intelligence that helps corporate counsel address both near and long-term challenges, […]...

Applied Cloud Computing partners with Snowflake to expand its data capabilities
newslanes.com
2022-10-16 11:57:04ACC to participate in Snowflake Data Cloud World Tour to be held in Mumbai, on 21st September 2022 MUMBAI, India, Sept. 20, 2022 /PRNewswire/ — Applied Cloud Computing (ACC), an emerging leader in the cloud technology space, announced its partnership with Snowflake, the Data Cloud Company, to expand its data capabilities in cloud computing and digital […] Applied Cloud Computing partners with Snowflake to expand its data capabilities...

ESPN, ACC, SEC And Other Disney Channels Gone From DISH Network
forbes.com
2022-10-01 20:29:29In a bold move, the Walt Disney Company forced Charlie Ergen's DISH Network and Sling TV to pull down the signals of all of its cable networks, including ESPN, ACC and SEC Network.

Global Automotive Radar Market, Size, Share, Key, Players, Demand, Growth, Analysis, Research, Report
headlinesoftoday.com
2022-10-01 12:31:59Automotive Radar Market Size Global Automotive Radar Market to be Driven by the Growing Application of the Product in the Adaptive Cruise Control (ACC) in the Forecast Period of 2022-2027 30 NORTH GOULD STREET, SHERIDAN, WYOMING, UNITED STATES, October 1, 2022 /EINPresswire.com/ — The new report by Expert Market Research titled, ‘Global Automotive Radar Market […]...

Aker Carbon Capture: Second-Quarter and Half-year Results 2025
prnewswire.com
2025-07-15 01:10:00FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Carbon Capture ASA ("ACC ASA") today publishes its second-quarter and half-year results for 2025. In the second quarter, ACC ASA made a strategic decision to divest its 20 percent ownership stake in SLB Capturi AS, through a sale to Aker which was completed 14 May 2025.

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
globenewswire.com
2025-04-15 08:00:00Precise Volume Measurement Prior to Discharge Identifies Mortality Risk Oak Ridge, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced compelling new data presented at the American College of Cardiology (ACC) 74th Annual Scientific Session and Expo held in Chicago from March 29-31st. Research from The Minneapolis Heart Institute Foundation® and Allina Health Minneapolis Heart Institute® demonstrated that hospitalized heart failure patients who received blood volume analysis (BVA) prior to hospital discharge could be used to stratify those with a substantially better survival rate.

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
globenewswire.com
2025-03-31 08:05:00SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago, IL. Drawing on data from more than 1.1 million patients who used iRhythm's Zio® long-term continuous monitoring (LTCM) ECG devices, these studies demonstrate that short-term (24–48-hour) monitoring, such as with Holter devices, fails to detect a significant proportion of actionable arrhythmias—even in patients reporting “daily symptoms”—and that Symptom–Rhythm Correlation (SRC) is notably low for most arrhythmias, underscoring that selection of monitoring duration based on the frequency of symptoms alone can lead to undetected (missed) actionable1 arrhythmias.

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
globenewswire.com
2025-03-29 14:33:00Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD)1. These new data from the phase 3b trial were featured during a late-breaking clinical trial session at the American College of Cardiology's (ACC) Annual Scientific Session and Expo in Chicago, US and simultaneously published today in New England Journal of Medicine 2.

Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology's Annual Scientific Session & Expo (ACC.25)
globenewswire.com
2025-03-29 14:30:00– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction (p=0.001), assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile –

ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
businesswire.com
2025-03-27 09:00:00CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway. GE HealthCare has been investing in.

ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
businesswire.com
2025-03-25 06:00:00WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American College of Cardiology (ACC) 74th Annual Scientific Session & Expo 2025, taking place in Chicago, IL, from March 29-31, 2025. Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for the treatment of adult pati.

BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions
globenewswire.com
2025-03-24 07:30:00PALO ALTO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that cardiovascular outcomes data in patients with variant and wild-type ATTR-CM from the ATTRibute-CM, its Phase 3 study of acoramidis in ATTR-CM, will be shared in a flatboard poster presentation at the American College of Cardiology (ACC) Annual Scientific Sessions & Expo, taking place in Chicago, Illinois on March 29-31, 2025. Additionally, BridgeBio was selected to share five poster presentations and two moderated posters on ATTR-CM.

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo
globenewswire.com
2025-03-19 07:30:00DUBLIN and BRIDGEWATER, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be presented at the American College of Cardiology's Annual Scientific Session & Expo, March 29-31, 2025, in Chicago, IL.

Stellantis-backed ACC to expand French gigafactory
reuters.com
2024-12-11 08:31:17Battery maker Automotive Cells Company (ACC) is set to sign a new loan to finance the second production block of its gigafactory in northern France, a company spokesman said, as it ramps up output despite Europe's sluggish electric vehicle market.

American Campus Communities Promotes Kim Voss as New Chief Financial Officer
businesswire.com
2022-11-14 17:50:00AUSTIN, Texas--( BUSINESS WIRE )--American Campus Communities (ACC), the nation's largest student housing manager, owner and developer has announced the promotion of Kim Voss to Chief Financial Officer (CFO).

Alternative Credit Managers Launch ESG Integrated Disclosure Tool
businesswire.com
2022-11-08 08:30:00NEW YORK & LONDON--(BUSINESS WIRE)--A group of leading alternative asset managers and industry bodies in the private and broadly syndicated credit markets have today announced the launch of the ESG Integrated Disclosure Project (ESG IDP) template.

Bloomberg Law to Feature Latest Legal Intelligence and Tools for Corporate Counsel at 2022 ACC Meeting
headlinesoftoday.com
2022-10-19 10:13:00ARLINGTON, Va., Oct. 19, 2022 /PRNewswire/ — Bloomberg Law today announced that it will highlight its resources and workflow tools at the annual meeting of the Association of Corporate Counsel (ACC) taking place in Las Vegas October 23-26. Bloomberg Law will showcase its legal intelligence that helps corporate counsel address both near and long-term challenges, […]...

Applied Cloud Computing partners with Snowflake to expand its data capabilities
newslanes.com
2022-10-16 11:57:04ACC to participate in Snowflake Data Cloud World Tour to be held in Mumbai, on 21st September 2022 MUMBAI, India, Sept. 20, 2022 /PRNewswire/ — Applied Cloud Computing (ACC), an emerging leader in the cloud technology space, announced its partnership with Snowflake, the Data Cloud Company, to expand its data capabilities in cloud computing and digital […] Applied Cloud Computing partners with Snowflake to expand its data capabilities...

ESPN, ACC, SEC And Other Disney Channels Gone From DISH Network
forbes.com
2022-10-01 20:29:29In a bold move, the Walt Disney Company forced Charlie Ergen's DISH Network and Sling TV to pull down the signals of all of its cable networks, including ESPN, ACC and SEC Network.

Global Automotive Radar Market, Size, Share, Key, Players, Demand, Growth, Analysis, Research, Report
headlinesoftoday.com
2022-10-01 12:31:59Automotive Radar Market Size Global Automotive Radar Market to be Driven by the Growing Application of the Product in the Adaptive Cruise Control (ACC) in the Forecast Period of 2022-2027 30 NORTH GOULD STREET, SHERIDAN, WYOMING, UNITED STATES, October 1, 2022 /EINPresswire.com/ — The new report by Expert Market Research titled, ‘Global Automotive Radar Market […]...